Projects By Category: Metabolic Disorders

Stay up to date with project updates from the Metabolic Disorders category.

Latest Industry Projects in Metabolic Disorders

Peginesatide (Hematide) – For the Treatment of Anaemia Associated with Chronic Kidney Disease
Peginesatide (Hematide) is an erythropoiesis-stimulating agent (ESA) under development for the treatment of anaemia associated with chronic kidney disease...
> read more

Januvia - DPP-IV inhibitor for Type 2 Diabetes Januvia (sitagliptin phosphate) is an antihyperglycaemic drug containing an orally active inhibitor of the dipeptidyl peptidase-IV (DPP-IV) enzyme. Developed by Merck Sharp & Dohme (MSD), a...

Lorcaserin, Investigational Oral Anti-Obesity Drug Lorcaserin hydrochloride (Lorcaserin) is an investigative oral treatment drug for obesity, and was discovered by Arena Pharmaceuticals (Arena), a clinical-stage biopharmaceutical company,...

Saxagliptin – Treatment for Type 2 Diabetes The product of a joint development programme between AstraZeneca and Bristol-Myers Squibb, saxagliptin is a member of...